In contrast, high-dose CDD treatment significantly downregulated the protein expression levels of IL6, JAK2, STAT3, p-STAT3, FOXO4, while upregulating the expression of GLUT4 compared with the PCOS-IR group (P < 0.05; Figure 6). The gene discussed is SLC2A4; the disease is polycystic ovary syndrome.